We have released our 2019/20 Annual Report

Learn More

CSL CEO Participates in White House Roundtable Urging COVID-19 Plasma Donations

Read About the Meeting

CSL to manufacture and supply University of Queensland and Oxford University vaccine candidates for Australia

Read The Findings

Popular search terms:

Paul Perreault

COVID-19: A Message from Our CEO

"As the COVID-19 pandemic evolves, CSL remains committed to safeguarding our patients, our donors and our people. In keeping with our values-based culture, CSL has taken precautions to ensure our employees and our facilities remain safe so we can continue to deliver on our promise to patients and public health." - Paul Perreault, CEO & Managing Director, CSL Limited

CSL Logo

COVID-19 Update

CSL continues to provide medicines to patients around the world.

11 Sep 2020
CSL Logo

CSL to manufacture and supply vaccine candidates

06 Sep 2020
CSL CEO Paul Perreault at White House Roundtable

At White House Roundtable, Paul Perreault Urges People to Donate Plasma in the Fight Against COVID-19

30 Jul 2020

Get to Know Us Better

Scientists in Marburg, Germany
Analytical Services Quality Employee Angelika Jung

Angelika Jung

Senior Manager, ASQ Group Leader External Materials & Sampling (Marburg, Germany)

Angelika has been with CSL Behring for nearly 20 years and in that time has grown from having no direct reports to leading a large team in our Quality group.

Watch Angelika's Story